ONE-MONTH HOSPITALIZATION WITH HIGH-DOSE GLUCOCORTICOID THERAPY IS ASSOCIATED WITH SARCOPENIA PROGRESSION IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES

被引:0
|
作者
Hanaoka, H. [1 ]
Kikuchi, J. [1 ]
Akiyama, M. [1 ]
Hiramoto, K. [1 ]
Saito, S. [1 ]
Kondo, Y. [1 ]
Kaneko, Y. [1 ]
机构
[1] Keio Univ, Div Rheumatol, Dept Internal Med, Sch Med, Tokyo, Japan
关键词
Diet and nutrition; Comorbidities; Best practices;
D O I
10.1136/annrheumdis-2023-eular.1734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1643
引用
收藏
页码:2056 / 2056
页数:1
相关论文
共 50 条
  • [41] HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE THERAPY ASSOCIATED WITH OSTEONECROSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    MASSARDO, L
    JACOBELLI, S
    LEISSNER, M
    GONZALEZ, M
    VILLARROEL, L
    RIVERO, S
    LUPUS, 1992, 1 (06) : 401 - 405
  • [42] Factors Associated with High-Dose Corticosteroid Use in SLE Patients Post Initiation of SLE Therapy
    Schroeder, Krista
    Gelwicks, Steve
    Paik, Jim
    Hoffman, Robert W.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [43] Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy
    Ueda-Sakane, Yoriko
    Kanamoto, Naotetsu
    Fushimi, Yasutaka
    Tanaka-Mizuno, Sachiko
    Yasuno, Shinji
    Miura, Masako
    Sone, Masakatsu
    Yasoda, Akihiro
    Okada, Tomohisa
    Togashi, Kaori
    Nakao, Kazuwa
    Inagaki, Nobuya
    ENDOCRINE JOURNAL, 2016, 63 (08) : 703 - 714
  • [44] ONE MONTH CHANGES OF LDL-C IN PATIENTS WITH ACS ON HIGH-DOSE STATIN THERAPY. PRELIMINARY RESULTS OF THE COMBI-LLT ACS STUDY
    Kovalskaya, A.
    Bikbaeva, G.
    Duplyakov, D.
    ATHEROSCLEROSIS, 2023, 379 : S167 - S168
  • [45] One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention ― Onyx ONE Clear 2-Year Results
    Kang, Jeehoon
    Ghapar, Abdul Kahar Abdul
    Selvaraj, Kamaraj
    Hur, Seung-Ho
    Tam, Chor Cheung
    Jang, Yangsoo
    Chae, In-Ho
    Kandzari, David E.
    Kirtane, Ajay J.
    Latib, Azeem
    Kedhi, Elvin
    Lung, Te-Hsin
    You, So-Jeong
    Windecker, Stephan
    Stone, Gregg W.
    Kim, Hyo-Soo
    CIRCULATION REPORTS, 2024, 6 (08) : 333 - 340
  • [46] One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
    Kandzari, David E.
    Kirtane, Ajay J.
    Windecker, Stephan
    Latib, Azeem
    Kedhi, Elvin
    Mehran, Roxana
    Price, Matthew J.
    Abizaid, Alexandre
    Simon, Daniel I.
    Worthley, Stephen G.
    Zaman, Azfar
    Choi, James W.
    Caputo, Ronald
    Kanitkar, Mihir
    McLaurin, Brent
    Potluri, Srinivasa
    Smith, Timothy
    Spriggs, Douglas
    Tolleson, Thaddeus
    Nazif, Tamim
    Parke, Maria
    Lee, Lilian C.
    Lung, Te-Hsin
    Stone, Gregg W.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (11) : E009565
  • [47] Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases
    Kameda, Hideto
    Amano, Koichi
    Nagasawa, Hayato
    Ogawa, Hiroe
    Sekiguchi, Naoya
    Takei, Hirofumi
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    INTERNAL MEDICINE, 2009, 48 (22) : 1931 - 1938
  • [48] Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in patients with systemic rheumatic diseases receiving moderate-to high-dose glucocorticoids
    Ohmura, Shin-ichiro
    Masui, Takayuki
    Yukishima, Toshitaka
    Ohkubo, Yusuke
    Yonezawa, Haruka
    Miyamoto, Toshiaki
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 1195 - 1201
  • [49] INTERMITTENT HIGH-DOSE VITAMIN-C THERAPY IN PATIENTS WITH HTLV-I-ASSOCIATED MYELOPATHY
    KATAOKA, A
    IMAI, H
    INAYOSHI, S
    TSUDA, T
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (11): : 1213 - 1216
  • [50] High-dose intravenous methylprednisolone therapy in patients with Graves' orbitopathy is associated with the increased activity of factor VIII
    Miskiewicz, P.
    Milczarek-Banach, J.
    Rutkowska-Hinc, B.
    Kondracka, A.
    Bednarczuk, T.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (02) : 217 - 225